- Home
- BOLT vs PRPH Comparison
BOLT vs PRPH Comparison
Compare BOLT & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- PRPH
- Stock Information
- Founded
- BOLT 2015
- PRPH 1989
- Country
- BOLT United States
- PRPH United States
- Employees
- BOLT N/A
- PRPH N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- BOLT Health Care
- PRPH Health Care
- Exchange
- BOLT Nasdaq
- PRPH Nasdaq
- Market Cap
- BOLT 16.8M
- PRPH 15.2M
- IPO Year
- BOLT 2021
- PRPH 1997
- Fundamental
- Price
- BOLT $5.91
- PRPH $0.40
- Analyst Decision
- BOLT Buy
- PRPH
- Analyst Count
- BOLT 3
- PRPH 0
- Target Price
- BOLT $50.00
- PRPH N/A
- AVG Volume (30 Days)
- BOLT 26.0K
- PRPH 4.1M
- Earning Date
- BOLT 08-12-2025
- PRPH 08-13-2025
- Dividend Yield
- BOLT N/A
- PRPH N/A
- EPS Growth
- BOLT N/A
- PRPH N/A
- EPS
- BOLT N/A
- PRPH N/A
- Revenue
- BOLT $3,638,000.00
- PRPH $5,845,000.00
- Revenue This Year
- BOLT N/A
- PRPH $221.82
- Revenue Next Year
- BOLT $24.14
- PRPH N/A
- P/E Ratio
- BOLT N/A
- PRPH N/A
- Revenue Growth
- BOLT N/A
- PRPH N/A
- 52 Week Low
- BOLT $5.20
- PRPH $0.22
- 52 Week High
- BOLT $15.60
- PRPH $4.03
- Technical
- Relative Strength Index (RSI)
- BOLT 47.01
- PRPH 61.98
- Support Level
- BOLT $5.52
- PRPH $0.32
- Resistance Level
- BOLT $6.21
- PRPH $0.37
- Average True Range (ATR)
- BOLT 0.33
- PRPH 0.03
- MACD
- BOLT 0.04
- PRPH 0.00
- Stochastic Oscillator
- BOLT 48.67
- PRPH 93.00
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.